iBio (IBIO) EBT Margin Growth (1y) (2012 - 2025)
iBio (IBIO) EBT Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -88,600.00 |
| Mar 31, 2022 | 62,692.00 |
| Sep 30, 2021 | -4.25 Mn |
| Jun 30, 2021 | -173,924.00 |
| Mar 31, 2021 | 386,913.00 |
| Dec 31, 2020 | 4,617.00 |
| Sep 30, 2020 | 230,225.00 |
| Jun 30, 2020 | 25,164.00 |
| Mar 31, 2020 | -406,932.00 |
| Dec 31, 2019 | -51,303.00 |
| Sep 30, 2019 | 565,130.00 |
| Jun 30, 2019 | 429,154.00 |
| Mar 31, 2019 | 428,438.00 |
| Dec 31, 2018 | 186,400.00 |
| Sep 30, 2018 | -664,603.00 |
| Jun 30, 2018 | -191,172.00 |
| Mar 31, 2018 | 683,032.00 |
| Dec 31, 2017 | 251,101.00 |
| Sep 30, 2017 | -45,990.00 |
| Jun 30, 2017 | 738,620.00 |